Koyfin Home > Directory > Health Care > Adma Biologics > Return on Equity %

Adma Biologics Return on Equity % Chart (ADMA)

Adma Biologics annual/quarterly Return on Equity % from 2011 to 2020.
  • Adma Biologics Return on Equity % for the quarter ending June 06, 2020 was -93.19 a -18.27% increase of 17.03 year over year
  • Adma Biologics Return on Equity % for the last 12 months ending June 06, 2020 was -99.24 a -53.24% increase of 52.84 year over year
  • Adma Biologics Annual Return on Equity % for 2019 was -210.08 a -4.14% increase of 8.69 from 2018
  • Adma Biologics Annual Return on Equity % for 2018 was -218.77 a -11.51% increase of 25.18 from 2017
  • Adma Biologics Annual Return on Equity % for 2017 was -243.95 a 539.99% decrease of -1,317.30 from 2016
Other Margins & Efficiency Metrics:
  • Adma Biologics EBITDA Margin for the quarter ending June 06, 2018 was $-270m a 24.55% decrease of -66m year over year
  • Adma Biologics Return on Capital % for the quarter ending September 09, 2018 was -40.32 a 8.20% decrease of -3.30 year over year
View Chart On Koyfin

Quarterly ADMA Return on Equity % Data

06/2020-93.19
03/2020-125.65
12/2019-135.59
09/2019-110.22
06/2019-185.61
03/2019-350.71
12/2018-253.27
09/2018-136.10
06/2018-157.76
03/2018-225.03

Annual ADMA Return on Equity % Data

2019-210.08
2018-218.77
2017-243.95
20161,073.36
2015-526.23
2014-121.91
2013-100.19
2012-148.86
2011333.45
2010526.97